Phase I Study of Apatinib in Combination with Gefitinib As First-Line Treatment in Patients with EGFR-Mutant Advanced Non-Squamous Non-Small Cell Lung Cancer
Keyword(s):
Phase I
◽
2017 ◽
Vol 6
(S1)
◽
pp. S62-S66
◽
Keyword(s):
Keyword(s):